AmerisourceBergen is the second-largest distributor of pharmaceuticals in the U.S. As such, it’s subject to many of the same forces affecting McKesson, its top competitor. Generic drug price deflation and fewer expected generic-drug launches will put pressure on overall industry profits this year and next. AmerisourceBergen has been working to counter those effects by entering new markets through strategic acquisitions. This includes getting into animal health distribution with MWI Veterinary Supply, compounding with PharMEDium, and clinical trial logistics with World Courier. AmerisourceBergen also could face a windfall of new revenue in coming years after its partner Walgreens absorbs Rite Aid and its more than 4,500 pharmacists.
News about AmerisourceBergen
Bold acquisitions and global expansion lifted Amerisource's ranking to number 12 on Fortune 500
Steve Collis predicts new era of where drug prices are going to come down.
Amazon and CVS are putting on the pressure.
Sparking a selloff in the shares of a host of health care-related companies.
Corporate governance matters, too.
Videos about AmerisourceBergen
Steven Collis says "intellectual confidence" is his most important leadership lesson.
Steve Collis says it will take a long time for Amazon to be a "significant force" in the drug business.